| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/29/2013 | CN103121972A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103120782A Chinese medicinal preparation for treating osteoporosis |
| 05/29/2013 | CN103120734A Traditional Chinese medicine drug for treating hyperostosis |
| 05/29/2013 | CN103120728A Chinese medicinal preparation for treating osteoporosis |
| 05/29/2013 | CN103120676A Application of Eryngiolide A in medicine for treating rheumatoid arthritis |
| 05/29/2013 | CN103120671A Application of Aphanamixoid A in medicine for treating rheumatoid arthritis |
| 05/29/2013 | CN103120655A Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 05/29/2013 | CN103120509A Drug pillow |
| 05/29/2013 | CN102626381B Vesicular phospholipid gel injection of latamoxef sodium |
| 05/29/2013 | CN102579583B External patch for treating injury of tendons |
| 05/29/2013 | CN102293825B Compound termitarium and preparation method thereof |
| 05/29/2013 | CN102258689B Medicine for treating traumatic injury and bonesetting |
| 05/29/2013 | CN102188688B Traditional Chinese medicine capable of treating cervical and lumbar vertebra hyperosteogeny |
| 05/29/2013 | CN101721422B Medicine for treating arthritis and preparation method thereof |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/29/2013 | CN101322734B Codonopsis lanceolata total saponins with anti-inflammatory immunity function and preparation thereof |
| 05/29/2013 | CN101235041B Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof |
| 05/29/2013 | CN101028325B Medicinal composition containing sailonggu, and its preparation and quality detection method |
| 05/28/2013 | US8450455 cRGD peptide derivative and its manufacture, and implant having a coating containing a cRGD peptide derivative |
| 05/28/2013 | US8450271 Peptide-based scaffolds for cartilage regeneration and methods for their use |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2710040C A soluble tumor necrosis factor receptor mutant |
| 05/28/2013 | CA2592891C Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2500663C Enteric composition for the manufacture of soft capsule wall |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 05/28/2013 | CA2440831C Combination therapy using cd40 and cd20 ligands |
| 05/23/2013 | WO2013074556A1 Methods of inducing chondrogenesis in mesenchymal stem cells using synthetic triterpenoids |
| 05/23/2013 | WO2013030669A3 Compositions comprising thymoquinone for the treatment of inflammatory diseases |
| 05/23/2013 | US20130131804 Joint Repair Using Mesenchymal Stem Cells |
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130131026 Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/22/2013 | EP2594274A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 05/22/2013 | EP2594268A1 Anti-angiogenic composition containing macrolactin a and a derivative thereof as active ingredients |
| 05/22/2013 | EP2593096A2 Diclofenac salt of tramadol |
| 05/22/2013 | CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103119039A Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 05/22/2013 | CN103114117A Method for preparing fish egg sugar protein with anti-osteoporosis effect |
| 05/22/2013 | CN103113375A Pyrazolo [3, 4-d] pyrimidine compounds and preparation method thereof |
| 05/22/2013 | CN103113353A Triazole compounds, medical composition thereof and preparation and application of triazole compounds |
| 05/22/2013 | CN103113307A 苯并咪唑类化合物及其应用 Benzimidazole compounds and their Applications |
| 05/22/2013 | CN103113303A Nitrogen heterocyclic compound used as CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells) receptor antagonist |
| 05/22/2013 | CN103110947A Additive used for activating platelets |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN103110933A Elcatonin composition and preparation method thereof |
| 05/22/2013 | CN103110925A Medicament for treating fracture |
| 05/22/2013 | CN103110880A External traditional Chinese medicine preparation for treating supraspinous muscle tendinitis |
| 05/22/2013 | CN103110863A Collateral-activating blood stasis-dispersing capsules |
| 05/22/2013 | CN103110817A Traditional Chinese medicine for treating diseases caused by spinal lesions |
| 05/22/2013 | CN103110775A Preparation method of transdermal absorption agent for podagra |
| 05/22/2013 | CN103110771A External traditional Chinese medicine preparation for treating thecal cyst |
| 05/22/2013 | CN103110769A Topical medicinal liquor for treating rheumatoid bone disease |
| 05/22/2013 | CN103110762A Traditional Chinese medicine composition for treating old fracture |
| 05/22/2013 | CN103110744A Traditional Chinese medical health-care preparation for increasing bone density and preparation method thereof |
| 05/22/2013 | CN103110739A Topical medicinal liquor and oral Chinese medicine for treating internal bone injury |
| 05/22/2013 | CN103110732A Traditional Chinese medicine wine for treating chondromalacia patellae |
| 05/22/2013 | CN103110719A Traditional Chinese medicine wine for treating kidney deficiency and essence depletion type osteoporosis |
| 05/22/2013 | CN103110716A Bone-knitting traditional Chinese medicine |
| 05/22/2013 | CN103110708A External-use plaster preparation for treating hyperosteogeny as well as preparation method and using method of external-use plaster |
| 05/22/2013 | CN103110700A Fraxinus mandshurica extract for treating rheumatoid arthritis |
| 05/22/2013 | CN103110699A Scraping therapy oil |
| 05/22/2013 | CN103110687A Compound effervescent preparation containing soy isoflavone |
| 05/22/2013 | CN103110679A Application of panax japonicus extract in preparing medicine of preventing osteoporosis |
| 05/22/2013 | CN103110606A Alfacalcidol capsules and preparation method thereof |
| 05/22/2013 | CN103110598A Alfacalcidol dispersible tablet and preparation method thereof |
| 05/22/2013 | CN102600101B Method for preparing sinomenine hydrochloride film-controlled enteric-coated tablets by non-organic solvents |
| 05/22/2013 | CN102600092B Method for preparing sinomenine hydrochloride tablets by non-organic solvents |
| 05/22/2013 | CN102600085B Method for preparing sinomenine sustained-release injection by using inorganic solvent |
| 05/22/2013 | CN102525976B Method for preparing strontium ranelate orally disintegrating tablets with fluidized bed |
| 05/22/2013 | CN102382187B FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene |
| 05/22/2013 | CN102366591B Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method |
| 05/22/2013 | CN102258475B Daidzein solid lipid nanoparticles and preparation method thereof |
| 05/22/2013 | CN102210697B Medicine composition for treating metabolic bone diseases |
| 05/22/2013 | CN102036959B Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 05/22/2013 | CN101921220B Pharmaceutical compositions for treating diseases with bone mass loss having EP4 agonist as the active ingredient |
| 05/22/2013 | CN101862331B New use of methyl liensinine |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101489573B Methods for treating autoimmune diseases using a TACI-Ig fusion molecule |
| 05/22/2013 | CN101426484B Application of a pharmaceutical composition in preparation of pharmaceutical for treating or preventing degenerative and inflammatory diseases |
| 05/21/2013 | US8445694 Hydrazonopyrazole derivatives and their use as therapeutics |
| 05/21/2013 | US8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 05/21/2013 | US8445462 Composition for the treatment of osteoarthritis |
| 05/21/2013 | CA2707766C Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/16/2013 | WO2013071262A1 Calcimimetics and methods for their use |
| 05/16/2013 | WO2013069404A1 Therapeutic agent for joint diseases |
| 05/16/2013 | WO2013068972A1 Nadph oxidase 4 inhibitors and use thereof |
| 05/16/2013 | WO2013068014A1 Pharmaceutical compositions comprising lubricants for preventing or reducing aseptic loosening in a subject |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | WO2013067591A1 Topical formulations for pain management |
| 05/16/2013 | WO2013015611A9 Composition for preventing damage to chondrocytes and regenerating same, including yeast hydrolysate as an active ingredient |
| 05/16/2013 | US20130123742 Method of a Pharmaceutical Delivery System for Use Within a Joint Replacement |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |